SCHEMBL19081845

SCHEMBL19081845

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc4c(c3)sc3c4ccc4oc5c6ccccc6ccc5c43)c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 15/20 0.40
CYP1B1 Q16678 15/20 0.40
LIMK1 P53667 2/20 0.35
LIMK2 P53671 1/20 0.35
CYP1A2 P05177 14/20 0.34
PRKDC P78527 3/20 0.34
ABCB1 P08183 2/20 0.34
ABCC1 P33527 2/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PDE5A O76074 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081835 0.93 CYP1A1 (0.40) CYP1A1CYP1B1LIMK1CYP1A2PRKDC
SCHEMBL19081952 0.92 LIMK1 (0.34) CYP1A1CYP1B1LIMK1LIMK2CYP1A2
SCHEMBL19081984 0.89 LIMK1 (0.36) CYP1A1CYP1B1LIMK1LIMK2CYP1A2
SCHEMBL18842988 0.89 PLA2G2A (0.34) CYP1A1CYP1B1LIMK1LIMK2CYP1A2
SCHEMBL19081880 0.86 CYP1A1 (0.38) CYP1A1CYP1B1LIMK1LIMK2CYP1A2
SCHEMBL19076741 0.85 ALOX5 (0.37) CYP1A1CYP1B1PRKDC
SCHEMBL17932251 0.85 PRKDC (0.38) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL17932264 0.85 ALOX5 (0.35) CYP1A1CYP1B1LIMK1CYP1A2PRKDC
SCHEMBL19081846 0.85 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2PRKDCABCB1
SCHEMBL19081800 0.84 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.